Anti-Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema: A Multicenter Study from the French Uveitis Network.
Ophthalmology
; 129(5): 520-529, 2022 05.
Article
in En
| MEDLINE
| ID: mdl-34793830
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Uveitis
/
Macular Edema
/
Vision, Low
Type of study:
Etiology_studies
/
Observational_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Ophthalmology
Year:
2022
Document type:
Article
Country of publication:
Estados Unidos